Faheez Mohamed

Consultant Surgeon Peritoneal Malignancy Institute Basingstoke

[Ville Sallinen @villesallinen]

New Impact Factors are out!

JAMA Surgery 14.9
BJS 8.8
Annals of Surgery 6.4
BJS Open 4.5
Dis Col Rectum 3.7
J Trauma 3.7
Ann Surg Oncol 3.5
JACS 3.4
EJSO 2.9
Surgery 2.7
Surg Endosc 2.7
Colorectal Dis 2.7
WJS 2.5
Hernia 2.4
HPB 2.4
JGIS 2.4
Langenbeck’s 1.8
Scand J Surg 1.8

[University Hospital Southampton 💙 @UHSFT]

One of our consultants @zaedHamady on the BBC talking about his new trial, the safe-D study, looking into early detection of pancreatic cancer. 🔬

https://t.co/teM6UKJD5i

[Paul Lewis @paullewismoney]

What an absolutely brilliant illustration. Stunning.

[Mesothelioma UK @Mesouk]

Did you know there are different types of mesothelioma, such as pleural & peritoneal? Peritoneal mesothelioma is a much rarer form.

Read more info here: https://t.co/8z4R3Gfcwq

#AMD2025

[The Independent @Independent]

Gen X and millennials 3X more likely to get appendix cancer than their parents https://t.co/TJkz1zCDZO

[SOuRCe @SOuRCe_RPA]

Newly published research by our Peritoneal Malignancy team assessing quality of life trajectories and surgical outcomes following CRS+HIPEC in two units in Australia and the United Kingdom. Read more: DOI 10.1097/DCR.0000000000003823.

#CRS #HIPEC #cancer #surgery

@SydneyLHD

[The BMJ @bmj_latest]

Patient author Georgina Johnson describes the compassion and support she received with a cancer diagnosis and getting the balance of information right
https://t.co/QYwBR2OlTm

[Alvaro Arjona @alarjosan]

First evidence for dysregulation of the genes of pivotal RNAregulatory in PMP, implying that these targetable mech may be functionally altered. @IMIBIC @HUReinaSofia @GrupoTTD @NewsJellybelly @acpmpresearch @PSOGI_EC @ISSPP1 @AssocAmarape @APeritoneum https://t.co/NYB0eY3uGD

[Frank Harrell @f2harrell]

1/2 @drjohnm has a wonderful piercing commentary about an incredibly harmful paper published in @CircAHA. The paper's authors use of the phrase "real world" is repugnant. (A problem w/ substack: can't add comments there unless you pay). https://t.co/m3eBDME3qs @EdgeforScholars

[RanD Spa @rand_spa]

RAND Spa is happy to attend the "Comprehensive Management of Peritoneal Surface Malignancy Workshop and PIPAC Course", taking place at the National Cancer Centre Singapore on April 14-16, under the direction of Prof. @ChiaClaramae , and endorsed by @PSOGI_EC
#HIPEC

[Mesothelioma UK Research Centre - Sheffield @meso_sheffield]

🌟We are delighted to share the first publication from our Pathways in Peritoneal Mesothelioma study. 🌟

Led by @sam_meso we highlight variations in care and make recommendations for change.

@Mesouk @EjegiMemeh @claregardiner8 @VirginiaSherbo2

https://t.co/cvY2rBWe9j

[Andreana N. Holowatyj @drholowatyj]

This new @NatureRevCancer article covers state of field in #appendicealcancer & defines the 1st research framework [below]—set to revolutionise the rare #cancer space. Honored to chair @acpmpresearch SA Board & Think Tank behind the effort! @OncoAlert

📃 https://t.co/EQlKaHH26x

[Pseudomyxoma Survivor @PMPSurvivor]

We are funding AI research @BasingstokePmi. Predicting PMP disease recurrence & survival, improve patient care & refine primary treatment protocols. Tim Brill, PS Trustee, surgeon Mr Mark Vasanth, Dr Sophia Stanford, Lead Research Scientist
#pseudomyxomasurvivor #appendixcancer

[Annals of Surgical Oncology @AnnSurgOncol]

January Issue: Selective #Gastrectomy with Knowledge of Gastric Anatomy and Blood Supply are Key to Complete Tumour Removal in Advanced #Pseudomyxoma : Single-Centre Experience with 120 Gastrectomies Over 20 Years. @VictorWSKung @FaheezM

https://t.co/jGXS5u5BIN

@SyedAAhmad5

[Syed A. Ahmad @SyedAAhmad5]

Experience is Key: Considerations of Gastrectomy During CRS/HIPEC for Extensive Pseudomyxoma Peritonei ⁦@AnnSurgOncol⁩ https://t.co/c1HJQCMQO2

[Pashtoon Kasi MD, MS @pashtoonkasi]

Value of different kind of 🩸#LiquidBiopsies in guiding care of our patients with #cancer.

Different platforms. Pros and cons to each approach. Boils down to the cancer type and clinical question. One size doesn’t fit all.

➕to assess treatment response.
https://t.co/o5LnECYlcy

[Annals of Surgical Oncology @AnnSurgOncol]

December Issue: Survival Analysis and Recurrence Patterns in 555 Patients with Colorectal #PeritonealMetastases Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy ( #CRSHIPEC ) @AllieviNiccolo

https://t.co/r0szPfqWwA

@SchultzKurt
@SyedAAhmad5

[Mesothelioma UK @Mesouk]

Sam has been joint principal investigator of a study exploring variability in patient pathways in peritoneal mesothelioma.

Read more about our research activity at: https://t.co/JEBEg0Aawx

@meso_sheffield

[Annals of Surgical Oncology @AnnSurgOncol]

#AudioVisualAbstract : Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy ( #CRSHIPEC ) to Treat #PseudomyxomaPeritonei of Ovarian Origin: A Retrospective French RENAPE Group Study @bakrinna @WGertych

https://t.co/e1pN9GXRBq

@scalpelmomma
@SyedAAhmad5

[Peritoneal Surface Oncology Group International @PSOGI_EC]

The 2nd session will be on zoom
in conjunction with @indepso

CASE DISCUSSION: Unresectable PMP treated by multivisceral transplant
with @PSugarbaker @Brendan92855812 @AnilV_AHEL #RamakrishnanAS
f/b A brief overview of multivisceral transplant for PMP by @AnilV_AHEL

🔗https://t.co/gqa4PHOg4v (free)

📅 22nd November, Friday
⏲️ 10-11.30 am EST
4.00-5.30 pm CET 🇪🇺
3.00-4.30 pm UK/Ireland 🇬🇧🇮🇪
11 am-12.30 pm Brazil 🇧🇷
8.30-10 pm India 🇮🇳
11.30 pm- 1.00 am Singapore 🇸🇬

@APeritoneum @SPeritoneum @AssocAmarape @NewsJellybelly @PMPSurvivor @acpmpresearch @RENAPE_Network @ISSPP1 @Some4SurgeryIT1 @SWexner @CNevrez @alarjosan @FarazKh65499316 @DrMikeValente @masato_fujiki @AndreasBrandl8 @FaekJ @Dr_Jamie_Murphy @LanaBijelicMD @SafakGuel @DeliaCortesGuir @oliviawriting @FaheezM